KOE:085660

Chabiotech Co.,Ltd. · KOE · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-08 13:43 UTC

Last close

n/aKRW

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-8.7%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
-17.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.1%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed

What it pays out is the furthest below its sector's middle: 0.01 against 0.36 on the market's range.

Follow one won

lens 1 of 9

After what it costs to make

25.6%

After running the business

-4.5%

After interest and tax

-8.7%

After what it must reinvest

-17.3%

Kept after the dividend

-17.3%

after what it costs to make, 25.6% of sales; after running the business, -4.5% of sales; after interest and tax, -8.7% of sales; after what it must reinvest, -17.3% of sales; kept after the dividend, -17.3% of sales

The five stops

5 of 5 read

After what it costs to make324,491,689,00025.6%
After running the business-57,146,888,000-4.5%
After interest and tax-109,876,118,000-8.7%
After what it must reinvest-219,088,569,000-17.3%
Kept after the dividend-219,507,558,000-17.3%

Of every unit of sales, -0.17 is still there after the dividend.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales1,268,253,669,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
After what it costs to make324,491,689,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
After running the business-57,146,888,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
After interest and tax-109,876,118,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
After what it must reinvest-219,088,569,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Kept after the dividend-219,507,558,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW